1Y Annualised Return
▼-23.63%
3Y Annualised Return
▼-38.02%
Nureca Stock Performance
|
|
|
Nureca Company background
Founded in: 2016
Managing director: Saurabh Goyal
Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Companys differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, DirecttoConsumer (D2C) Excellence and InHouse Manufacturing Capabilities. The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives.In 2017, the Company commenced business operations and launched Dr. Trust brand through digital healthcare channel.In 2018, the Company widened product basket with launching of brands in electric massages and mother child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Companys key products secured a warehouse drug license.In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited and the Company and their respective shareholders and creditors and the Scheme became effective on 23 May 2020. Pursuant to Scheme of Demerger, certain portion of business activities of Nectar Biopharma Private Limited was transferred by Nectar Biopharma Private Limited from 01 April, 2019.Nureca Technologies Private Limited have received industrial policy approval to establish a health and wellness equipment manufacturing plant at Village Sundra, SAS Nagar, Punjab in FY 25.
Nureca Financial Highlights
Nureca reported a Q2 FY 2025-26
revenue of ₹37.74 crore,
up 19.2% YoY,
with net profit decreased
-147.5% to ₹3.63 crore. For the full year FY2025–2026, revenue
reached ₹122.1 crore and profit touched at
₹0.85 crore.
Nureca Share Price Today
As of 3 Nov 2025, Nureca share price is ₹255.5. The stock opened at ₹260 and had closed at ₹261.5 the previous day. During today’s trading session, Nureca share price moved between ₹251.00 and ₹260.05, with an average price for the day of ₹255.53. Over the last 52 weeks, the stock has recorded a low of ₹203.62 and a high of ₹447.50. In terms of performance, Nureca share price has increased by 12.9% over the past six months and has declined by 23.63% over the last year.
Nureca SIP Return Calculator
Over the past
1 year
3 years
Total Investment of ₹1,80,000
Monthly SIP of ₹5,000 would have become ₹1,04,862 in 3 years with a gain of ₹-75,137 (-41.74%)
Nureca Fundamental
Market Cap (in crs)
261.50
Face Value
10
Turnover (in lacs)
11.79
Key Metrics
Qtr Change %
42.91% Fall from 52W High
6
Dividend yield 1yr %
0
Nureca Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Nureca Quarterly Revenue
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
37.74 Cr | 34.18 Cr | 31.74 Cr | 26.46 Cr | 31.19 Cr |
Nureca Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
122.1 Cr | 102.44 Cr | 118.43 Cr | 263.24 Cr | 216.27 Cr | 101.79 Cr |
Nureca Quarterly Net Profit/Loss
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
3.63 Cr | 0.81 Cr | 2.47 Cr | -2.8 Cr | -0.48 Cr |
Nureca Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
0.85 Cr | -1.79 Cr | -8.25 Cr | 44.96 Cr | 46.37 Cr | 6.41 Cr |
Nureca Result Highlights
Result Summary
-
Nureca Ltd reported a 9.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.6%.
-
Its expenses for the quarter were down by 0.1% QoQ and up 3.0% YoY.
-
The net profit increased 348.1% QoQ and decreased 856.3% YoY.
-
The earnings per share (EPS) of Nureca Ltd stood at 3.63 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Nureca Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
256
Current Price
5Day EMA
273.80
10Day EMA
277.50
12Day EMA
276.50
20Day EMA
270.50
26Day EMA
266.80
50Day EMA
259.40
100Day EMA
257.30
200Day EMA
263.70
5Day SMA
277.60
10Day SMA
295.30
20Day SMA
265.40
30Day SMA
255.60
50Day SMA
253.10
100Day SMA
258.40
150Day SMA
252.70
200Day SMA
260.60
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 15248 Rs | 15248 Rs |
Week Rs | 70271 Rs | 129639 Rs |
Month Rs | 53886 Rs | 164703 Rs |
Resistance & Support
263.48
Pivot
Resistance
First Resistance
266.97
Second Resistance
272.43
Third Resistance
275.92
Support
First Support
258.02
Second support
254.53
Third Support
249.07
Relative Strength Index
48.20
Money Flow Index
80.05
MACD
9.71
MACD Signal
11.56
Average True Range
18.34
Average Directional Index
34.67
Rate of Change (21)
13.46
Rate of Change (125)
16.74
Nureca Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76.89 | 98.86 | 63.56 | 102.35 | 74.82 | 2.52% | 11.05% | 17.64% | -19.49% | 116.29% | 0.00% | 14.93 | 25.32 | 3.67 | |
103.65 | 246.71 | 51.1 | 116 | 104.78 | -7.83% | 23.61% | 46.92% | 75.83% | 93.38% | 0.00% | 39.99 | 25.32 | 0.59 | |
270.30 | 95.38 | 61.11 | 283.15 | 265.00 | 0.22% | 20.45% | 291.17% | 114.10% | 92.04% | 0.00% | 90.75 | 91.43 | 6.86 | |
835.10 | 9,140.67 | 637.5 | 1045.3 | 762.85 | 10.14% | 11.85% | 4.29% | 22.94% | 41.37% | 0.00% | 205.08 | 190.56 | 7.37 | |
600.00 | 999.05 | 533 | 840 | 601.05 | -1.10% | -1.33% | -4.56% | -1.75% | 0.00% | 0.00% | 60.41 | 490.60 | 8.32 | |
314.35 | 1,726.91 | 302 | 584 | 314.20 | 0.19% | -4.70% | -18.93% | 0.00% | 0.00% | 0.00% | 91.93 | 91.43 | 7.76 |
Nureca Share Price FAQs
What is Share Price of Nureca ?
Nureca share price is ₹256 in NSE and ₹255.3 in BSE as on 3/11/2025.
How has Nureca shares performed in the past ?
Nureca share price in the past 1-year return was -14.1. The Nureca share hit a 1-year low of Rs. 203.62 and a 1-year high of Rs. 447.5.
What is the market cap of Nureca ?
The market cap of Nureca is Rs. 261.5 Cr. as of 3/11/2025.
What is the current P/E ratio of Nureca ?
The PE ratios of Nureca is 106.46 as of 3/11/2025.
What is the current PB ratio of Nureca ?
The PB ratios of Nureca is 1.34 as of 3/11/2025
How to buy Nureca shares?
You can easily buy Nureca shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Nureca ?
The 52-week high and low of Nureca share price is ₹447.5 and ₹203.62 as of 3/11/2025.
What is the EPS of Nureca ?
The earnings per share (EPS) of Nureca stood at 3.63 during Q2 FY 2025-26.
Please be aware that Nureca stock prices are subject to continuous fluctuations due to various factors.
Invest in Nureca